Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/30/2024
Chinese I/O Therapy Developer LTZ Raises $20M
7/30/2024
Merck Reports Lower China Revenue in H1/2024 amid Gardasil Decline, Po...
7/30/2024
Shanghai Pledges Millions to Boost Chinese Drugmakers in Global Market...
7/29/2024
BeiGene CEO Mulls Biologics Partnerships for New Innovation Center in ...
7/29/2024
Tigermed Acquires Japanese CRO Medical Edge
7/29/2024
Sunthetica Biotech Completes First Round Financing, Led by Boehringer ...
7/29/2024
Roche Reports 8% Rise in Global Pharma Sales, As Its China Revenues Su...
7/29/2024
NHSA Reports Steady Improvement of China's Basic Medical Insurance Sys...
7/26/2024
CStone Announces EC Approval of Sugemalimab (Cejemly®) as First-Line ...
7/26/2024
CDE Solicits Public Comments on the Pharmaceutic Self-Assessment Repor...
7/26/2024
Recent Official and Executive Moves
7/26/2024
Congress targeting trials at Chinese Military Hospitals and in Xinjian...
7/25/2024
AI-Assisted Development of BGM0504: A Promising GLP-1R/GIPR Dual Agon...
7/25/2024
NMPA Accept Belief BioMed's NDA for China's First Gene Therapy for Hem...
7/25/2024
CDE Solicits Public Comments on the Technical Guidelines for Quality C...
7/25/2024
CDE Solicits Public Comments on the Technical Guidelines for Model-Gui...
7/25/2024
Merck Group CEO Envisions AI-Driven Pharmaceutical Innovation Ecosyste...
7/25/2024
Innorna Receives IND Clearance for IN001 Herpes Zoster mRNA Vaccine in...
7/24/2024
CDE Solicits Public Comments on the Technical Guideline for the Study ...
7/24/2024
CDE Solicits Public Comments on the Guidelines for Setting Limits on R...
7/24/2024
Pfizer China President Praises China 's Reforms for Boosting Innovatio...
7/24/2024
BeiGene Opens New Clinical R&D and Biologics Manufacturing Facility in...
7/24/2024
Pharmanovia to Continue Expansion and Investment in China
7/24/2024
Why (And How) to HIDE Your IP from an Increasingly Rapacious China (Mo...
7/24/2024
Breaking Barriers and Accelerating Growth: Clinical Trials, Drug Appro...
7/23/2024
Fosun and Kite Pharma Agree to Convert Debt to Equity, Increasing JV F...
7/23/2024
Triastek Announces Research License Deal with BioNTech to Advance 3D P...
7/23/2024
Aligos Partners with Xiamen Amoytop Biotech for New CHB Treatment Stud...
7/23/2024
NHSA Issues the DRG and DIP Grouping Plans V2.0
7/23/2024
Global Drugmakers Pursue Deals in China Despite Tensions
Page:
43
/
762
Total number of articles:
22840
:
[First]
[<<]
[41]
[42]
[43]
[44]
[45]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit